---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-014775"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:28:24.404107+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q2 revenue up 34% to $670M, adjusted EBITDA turns positive at $7M

## Summary
- Revenue $670M (+34% YoY); normalized growth 42% excluding prior-year retroactive contract.
- Net loss narrowed to $21M from $299M loss in Q2 2021 which included $275M non-cash stock comp.
- Medical margin $82M (+49% YoY), 12.2% of revenue vs 11.1% a year ago.
- Total members on platform 351,700; MA membership up 44% YoY, same-geography growth 13%.
- FY 2022 guidance: revenue $2.615-2.635B, adjusted EBITDA $0-10M, total members 345-355K.

## SEC filing metadata
- accession: 0000950170-22-014775
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/0000950170-22-014775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017022014775/agl-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-014775
- JSON: https://secwatch.observer/filing/0000950170-22-014775.json
- Plain text: https://secwatch.observer/filing/0000950170-22-014775.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.